In a recent research report by Maximize Market Research, the Global Market for Anti-Obesity Drugs is expected to exceed US$ XX million by the year 2026, from US$ XX million in 2019.
Increasing prevalence of obesity and diabetes, ongoing research & development activities, increase in R&D funding, the launch of new novel drugs, ease of accessibilities and increase in demand for cost-effective products propel the global Anti-Obesity Drugs market.
The report published by Maximize, encompasses the various market dynamics, which could affect the market growth of Anti-Obesity Drugs in the region, the Value – Chain analysis, and the PORTER’s analysis for the Anti-Obesity Drugs market at a global level.
The study is consolidated on the basis of three major segments and further into sub-segments, By Mechanism of Action (Peripherally Acting Drugs, Centrally Acting Drugs), By Drug Type (Prescription Drugs, OTC Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, E-commerce), to forecast the market size by value; also includes the analysis of past market dynamics from 2016 to 2019, considering 2019 as the base year.
Lastly, the market research report provides a regional comparison and a complete country-level analysis for the latest trends, along with the major key players (Arena Pharmaceuticals Inc., Takeda Pharmaceuticals Company Limited, Zydus Cadila, Rhythm Pharmaceuticals, Merck & Co. Inc., Eisai Co. Ltd., Novo Nordisk A/S, Orexigen Therapeutics Inc., GlaxoSmithKline PLC, F. Hoffmann-La Roche, Shionogi Inc., Norgine B.V., Pfizer Inc., Zafgen) in the Anti-Obesity Drugs market, across the region.
You can browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on the “Global Anti-Obesity Drugs Market.”
https://www.maximizemarketresearch.com/market-report/global-anti-obesity-drugs-market/100768/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, Vadgaon Bk,
Sinhagad Road, Pune – 411051, Maharashtra, India.
+91 9607195908